Sulodexide in venous disease

56Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

Summary: Sulodexide is a glycosaminoglycan extracted from porcine intestinal mucosa. The purpose of this review is to discuss sulodexide's complex pharmacological profile and its clinical applications for venous disease. Sulodexide has wide-ranging biological effects on the vascular system, including antithrombotic, profibrinolytic, anti-inflammatory, endothelial protective and vasoregulatory effects. Sulodexide has emerged as a potential therapeutic option for the management of chronic venous insufficiency, including venous ulceration, and the prevention of recurrent venous thromboembolism, with a low rate of major bleeding complications. Sulodexide's pleiotropic vascular effects may facilitate the management of common venous disorders.

Cite

CITATION STYLE

APA

Carroll, B. J., Piazza, G., & Goldhaber, S. Z. (2019, January 1). Sulodexide in venous disease. Journal of Thrombosis and Haemostasis. Blackwell Publishing Ltd. https://doi.org/10.1111/jth.14324

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free